These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21923679)

  • 1. Helicobacter pylori therapy demystified.
    Graham DY; Dore MP
    Helicobacter; 2011 Oct; 16(5):343-5. PubMed ID: 21923679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding and appreciating sequential therapy for Helicobacter pylori eradication.
    Graham DY; Rimbara E
    J Clin Gastroenterol; 2011 Apr; 45(4):309-13. PubMed ID: 21389810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel and Effective Therapeutic Regimens for
    Hu Y; Zhu Y; Lu NH
    Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence-based recommendations for successful Helicobacter pylori treatment.
    Wu JY; Liou JM; Graham DY
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):21-8. PubMed ID: 24410470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified sequential therapy regimens for Helicobacter pylori eradication: a systematic review.
    Zullo A; De Francesco V; Hassan C; Ridola L; Repici A; Bruzzese V; Vaira D
    Dig Liver Dis; 2013 Jan; 45(1):18-22. PubMed ID: 23022424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological therapy used in the elimination of Helicobacter pylori infection: a review.
    Dos Santos AA; Carvalho AA
    World J Gastroenterol; 2015 Jan; 21(1):139-54. PubMed ID: 25574087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good bugs and bad bugs: indications and therapies for Helicobacter pylori eradication.
    Kuipers EJ; Janssen MJ; de Boer WA
    Curr Opin Pharmacol; 2003 Oct; 3(5):480-5. PubMed ID: 14559092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of Helicobacter pylori: current perspectives.
    Malhotra S; Pandhi P
    Expert Opin Pharmacother; 2002 Aug; 3(8):1031-8. PubMed ID: 12150683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Helicobacter pylori therapies in a clinical practice setting.
    Fennerty MB; Lieberman DA; Vakil N; Magaret N; Faigel DO; Helfand M
    Arch Intern Med; 1999 Jul; 159(14):1562-6. PubMed ID: 10421278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
    Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
    Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line
    Yeo YH; Shiu SI; Ho HJ; Zou B; Lin JT; Wu MS; Liou JM; Wu CY;
    Gut; 2018 Jan; 67(1):20-27. PubMed ID: 27670375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategies for Helicobacter pylori infection.
    Marshall BJ
    Gastroenterol Clin North Am; 1993 Mar; 22(1):183-98. PubMed ID: 8449566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori therapy: a paradigm shift.
    Graham DY; Dore MP
    Expert Rev Anti Infect Ther; 2016 Jun; 14(6):577-85. PubMed ID: 27077447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient identification and evaluation of effective Helicobacter pylori therapies.
    Graham DY
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):145-8. PubMed ID: 19026766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Rescue' therapies for the management of Helicobacter pylori infection.
    Di Mario F; Cavallaro LG; Scarpignato C
    Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies.
    Realdi G; Dore MP; Piana A; Atzei A; Carta M; Cugia L; Manca A; Are BM; Massarelli G; Mura I; Maida A; Graham DY
    Helicobacter; 1999 Jun; 4(2):106-12. PubMed ID: 10382124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication rate of Helicobacter Pylori infection is directly influenced by adherence to therapy in children.
    Kotilea K; Mekhael J; Salame A; Mahler T; Miendje-Deyi VY; Cadranel S; Bontems P
    Helicobacter; 2017 Aug; 22(4):. PubMed ID: 28303625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Helicobacter pylori infection.
    O'Connor A; Gisbert J; O'Morain C
    Helicobacter; 2009 Sep; 14 Suppl 1():46-51. PubMed ID: 19712168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication therapy research: Ethical issues and description of results.
    Graham DY
    Clin Gastroenterol Hepatol; 2010 Dec; 8(12):1032-6. PubMed ID: 20656062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key points for designing and reporting Helicobacter pylori therapeutic trials: a personal view.
    Calvet X; Gisbert JP; Suarez D
    Helicobacter; 2011 Oct; 16(5):346-55. PubMed ID: 21923680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.